Related Experiment Video
Updated: Jul 16, 2026

Generation of Human CD40-activated B cells
Published on: October 16, 2009
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation
1The Roskamp Institute, University of South Florida, 3515 East Fletcher Avenue, Tampa, FL 33613, USA.
Abstract:
Alzheimer's disease (AD) has a substantial inflammatory component, and activated microglia may play a central role in neuronal degeneration. CD40 expression was increased on cultured microglia treated with freshly solublized amyloid-beta (Abeta, 500 nanomolar) and on microglia from a transgenic murine model of AD (Tg APPsw). Increased tumor necrosis factor alpha production and induction of neuronal injury occurred when Abeta-stimulated microglia were treated with CD40 ligand (CD40L). Microglia from Tg APPsw mice deficient for CD40L demonstrated reduction in activation, suggesting that the CD40-CD40L interaction is necessary for Abeta-induced microglial activation. Finally, abnormal tau phosphorylation was reduced in Tg APPsw animals deficient for CD40L, suggesting that the CD40-CD40L interaction is an early event in AD pathogenesis.
Insights
Alzheimer's disease involves inflammation, with microglia playing a key role. Targeting the CD40-CD40L interaction in microglia may reduce amyloid-beta-induced activation and tau pathology in Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) pathogenesis involves significant neuroinflammation.
- Activated microglia are implicated in neuronal degeneration within AD.
Purpose of the Study:
- To investigate the role of the CD40-CD40L pathway in amyloid-beta (Abeta)-induced microglial activation and its impact on AD pathology.
- To determine if inhibiting CD40-CD40L signaling can mitigate AD-related neuroinflammation and neuronal damage.
Main Methods:
- Cultured microglia were treated with Abeta and CD40 ligand (CD40L).
- Microglia from a transgenic AD mouse model (Tg APPsw) with and without CD40L deficiency were analyzed.
- Tumor necrosis factor alpha (TNF-alpha) production and neuronal injury were assessed.
- Tau phosphorylation levels were measured in Tg APPsw mice deficient for CD40L.
Main Results:
- Abeta stimulation increased CD40 expression on microglia.
- Treatment of Abeta-stimulated microglia with CD40L elevated TNF-alpha production and induced neuronal injury.
- Microglia from Tg APPsw mice lacking CD40L showed reduced activation.
- Deficiency in CD40L in Tg APPsw mice led to reduced abnormal tau phosphorylation.
Conclusions:
- The CD40-CD40L interaction is crucial for Abeta-induced microglial activation in Alzheimer's disease.
- This interaction appears to be an early event in AD pathogenesis, influencing tau phosphorylation.
- Targeting the CD40-CD40L pathway presents a potential therapeutic strategy for AD.
Related Concept Videos
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

